| By Catalent Pharma Solutions |
| Monday, 04 May 2009 |
 |
Catalent Pharma Solutions, one of the leading providers of advanced technologies and outsourced services to the global pharmaceutical, biotechnology and consumer health industry, announces the purchase of a next-generation 10-color KBA RAPIDA™ 106 printing press at its Printed Components facility in Dublin, Ireland.
|
|
Due to be installed in June 2009, the KBA RAPIDA 106 is part of an ongoing investment in the Dublin plant to support the growth of European Printed Components business.
The press is capable of printing 15,000 sheets per hour and features a unique combination of advanced systems that provide transparent assurance of print quality and product integrity throughout the print run.
Fitted with the unique QualiTronic™ full-sheet scanning system which KBA developed for its currency printing presses, the QualiTronic camera scans each sheet at over three million pixels of resolution in full production speed.
The image is then inspected and compared to an approved master sheet for any inconsistencies or deviations. If any deviations are found, the sheet is marked for removal downstream.
|
|
|
The system can also detect any minute color changes and automatically adjust the press in a closed-loop sequence, without the need for operator intervention.
The press also has a Simultaneous Plate Changing (SPC™) system for rapid make-readies and PlateIdent to reduce run-up waste and ensure correct sequencing.
Its innovative 2-over-8 configuration offers the ultimate in efficiency, enabling for the first time the concurrent production and make ready of alternate jobs on a single press, reducing downtime to a minimum.
This provides the flexibility needed to effectively service both high and low volume jobs without sacrificing the superb quality, resolution and color of true offset printing. The press also runs at low energy consumption levels, which supports Catalent’s efficiency goals and benefits its customers through improved carbon footprint audits.
“The KBA Press brings a variety of innovative capabilities specifically tailored to meet the changing needs of our customer base,” said Victor Dixon, Vice President and General Manager of Catalent’s Printed Components business.
“It introduces a higher standard in pharmaceutical carton supply and follows our investment in similar |
|
technology upgrades at our plants in the U.S. and Puerto Rico. Our Dublin plant, which has served the pharmaceutical and healthcare market since it opened in 1989, has continually raised the bar for others to follow, and again leads its competitors with this investment.”
About Catalent
Headquartered in Somerset, New Jersey, Catalent is one of the leading providers of advanced dose form and packaging technologies, and development, manufacturing, packaging and printing services for pharmaceutical, biotechnology and consumer healthcare companies in nearly 100 countries.
Catalent applies its local market expertise and technical creativity to advance treatments, change markets and enhance patient outcomes.
Catalent employs approximately 9,100 at more than 30 facilities worldwide and in fiscal 2008 generated more than $1.8 billion of annual revenue.
Want to read more?
Rexam Pharma New Technical Paper - Implanting new ideas into next generation depot syringes
Rexam Annual Report
Benson Group Moves into Pharma Labels Sector |
|
|
